Why the study?
Does cyclophosphamide therapy improve symptoms and cause tumour regression in patients with postmastectomy lymphangiosarcoma?
Does cyclophosphamide therapy improve symptoms and cause tumour regression in patients with postmastectomy lymphangiosarcoma?
Cyclophosphamide therapy may provide temporary symptomatic improvement and tumour regression in patients with postmastectomy lymphangiosarcoma.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for cyclophosphamide in postmastectomy lymphangiosarcoma; controlled trials needed before clinical adoption.
Two cases of lymphangiosarcoma developing in oedematous arms following radical mastectomy (Stewart-Treeves syndrome) are reported. Both patients showed marked symptomatic improvement and tumour regression on cyclophosphamide therapy although remission was only temporary.
No takes yet. Share an insight, caveat, or question.
Tong et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: